Australia's largest stock trading and investment forum Australia's #1 stock forum

Apology needed for entire population, page-60

First 60 Last

Share
Profile

Follow
cjstew

221 Posts.

15/06/24

19:40

Post #: 74333277
Share

Originally posted by pintohoo ↑

''I can wait haha''

you and the rest of the bullshit peanut brigade - if you have a need for it and when it's successful - will fall over yourselves to get a working vaccine

the last thing you'll want to do is to wait ------- the epitome of hypocrisy

The latest and most significant development in vaccines for skin cancer is the ongoing phase 3 clinical trial of the world's first personalized mRNA cancer vaccine for melanoma, the deadliest form of skin cancer. [1][2][3][4][5]
## Key Points
- The vaccine, called mRNA-4157 (V940), is a personalized neoantigen therapy designed to stimulate the immune system to combat a patient's specific type of melanoma tumor.
- It is being developed by Moderna and Merck, and works by carrying coding for up to 34 neoantigens (tumor-specific markers) to trigger an anti-tumor immune response based on the unique mutations in a patient's cancer.
- The vaccine is custom-built for each patient by sequencing their tumor DNA and using AI to identify the neoantigens, making it a truly personalized treatment. [1]
- In a phase 2 trial, patients who received the mRNA vaccine along with the immunotherapy drug Keytruda were 49% less likely to die or have their cancer return after 3 years compared to those who received only Keytruda. [1][3]
- Based on these promising results, a global phase 3 trial involving around 1,100 melanoma patients has now commenced, with the UK arm aiming to recruit 60-70 patients across 8 centers. [1][2]
- One of the first UK patients, Steve Young, expressed excitement about the trial, calling it his "best chance at stopping the cancer in its tracks." [1][2]
- If successful, the personalized mRNA vaccine could be a game-changer in melanoma treatment, potentially leading to a cure for some patients. Experts have hailed it as a "finely honed tool" and "one of the most exciting things seen in a long time." [1][2][4][5]
The personalized mRNA vaccine represents a revolutionary new approach in cancer treatment, harnessing the body's own immune system to fight the disease in a highly targeted and customized manner. [5] The ongoing phase 3 trial results will determine if this cutting-edge therapy can be approved for broader use against melanoma and potentially other cancers in the future.

[1] https://www.theguardian.com/society/2024/apr/26/cancer-mrna-vaccine-melanoma-trial
[2]
[3] https://www.reuters.com/business/he...vival-benefit-long-term-follow-up-2024-06-03/
[4] https://www.nature.com/articles/d41586-024-01717-x
[5] https://theconversation.com/persona...ary-new-approach-in-melanoma-treatment-229047

Expand

Why is this been call a "Vaccine"
It does not stop you getting cancer, and in fact you have to have the cancer first before they can personalize the "Treatment"

Even the article states

making it a truly personalized treatment.

could be a game-changer in melanoma treatment

represents a revolutionary new approach in cancer treatment
1 Upvote

Reply

Top Stories

ASX Market Open: ASX200 to rise for Friday session | July 26

NVA

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

RHK

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

HRZ

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

MND

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

IGO

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

MIN

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Nine's staff strike as Paris Olympic coverage begins

There are more pages in this discussion • 60 more messages in this thread...

First 60 Last

Apology needed for entire population, page-60

ASX Market Open: ASX200 to rise for Friday session | July 26

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Nine's staff strike as Paris Olympic coverage begins

Featured News

Featured News

Apology needed for entire population, page-60

Top Stories

ASX Market Open: ASX200 to rise for Friday session | July 26

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Nine's staff strike as Paris Olympic coverage begins

Featured News

Featured News